Loading

Inflammatory Mediators of Hypertrophic Adenoids in Children with Otitis Media with Effusion

Review Article | Open Access | Volume 9 | Issue 2

  • 1. Department of Paediatric Laboratory Diagnostics, Medical University of Bialystok, Poland
  • 2. Department of Paediatric Oncology and Hematology, Medical University of Bialystok, Poland
+ Show More - Show Less
Corresponding Authors
Beata ?elazowska-Rutkowska, Department of Paediatric Laboratory Diagnostics, Medical University of Bialystok, Waszyngtona St. 17, 15–274 Bia?ystok, Poland, Tel: 4885-745-0743; Email: beata.zelazowskab@umb.edu.pl
ABSTRACT

Adenoid is lymphoid tissues in the pharynx that play an important role in host defense against invading antigens. The structures of adenoid consist of well-defined microcompartments which all participate in the immune response: the follicular germinal center, the mantle zone, the interfollicular area and the crypt epithelium. Otitis media with effusion (OME) is a common middle ear disease in children, but etiology of this disease is not clearly understood. Immunologic reaction within adenoid, pro-inflammatory cytokines (Th1 and Th2), decrease of lymphocytes T and B, metaloproteinase may lead to chronic infection.

KEYWORDS

• Lymphocytes T and B

• Adenoid

• Cytokine

• VEGF

• MMP

• Apoptosis

CITATION

?elazowska-Rutkowska B, Latoch E (2022) Inflammatory Mediators of Hypertrophic Adenoids in Children with Otitis Media with Effusion. Ann Otolaryngol Rhinol 9(2): 1284.

INTRODUCTION

Adenoid

Adenoid play an important role in host defenses of the upper respiratory tract against invading antigens. Lymphoid tissue develops after birth. It reaches maximum size during early childhood and starts to regress at the age of 8-10 years [1]. These tissues have four histological compartments which are very important in the immune response: the follicular germinal center, the mantle zone, the interfollicular area and the crypt epithelium [2] (Figure 1).

Figure 1 The schema construction of adenoid with lymphoid interval.

Figure 1: The schema construction of adenoid with lymphoid interval.

Germinal center reaction is characterized by large amounts of rapid clonal expansion and is generally polarized into two distinct zones. The dark zone is proximal lymphocytes T and contains proliferating B cells, called centroblasts, while the light zone contains noncykling B cells called centrocytes. Lymphocytes T provide help to B cells via CD40-CD40L interaction and cytokine production. Lymphocytes B provide –MHC class II complexes in the context to stimulatory production T cells and cytokine. Dendritic cells (DC) are found in the region between T and B cell zone [3]. The role of dendritic cells is to participate in polarization of immunological response to Th1 or Th2 which is necessay of rolling inflammatory process in middle ear [4]. Analysis of plasmoid PDCs (BDCA-2+ , CD 123+ , CD 11c) and myeloid MDCs (BDCA-1, CD1c+ , CD 11c++) DC in adenoid and blood in patients with adenoid hypertrophy and otitis media with effusion prove the higher levels of PDCs in adenoid than in the peripheral blood [5].

The etiology of hypertophic adenoid in children with or without otitis media with effusion is not exactly known. The literature shows that there is an increased expression of several inflammatory response mediators of adenoid which may lead to hypertrophy and chronic infections and eustachian tube dysfunction [2].

The role of Th1 and Th2 cytokines in hypertrophic adenoid

Effusion fluid in the middle ear contained acid phosphatase, mucin, alkaline phosphatase, cytokines, creatine phosphokinase and immunoglobulin producing cells [6]. Bacteria can trigger cytokine secretion of macrophages and monocytes as well as TLR expression. Gram–negative bacteria tend to induce expression of IL-6, IL-10, IL-8 but gram-positive bacteria tend to induce expresion of TNF-α, IFN-γ and IL-12 [7]. Subgroup T helper cellsTh17 producting proinflammatory IL-17 and developmentally, different from Th1 and Th2 cells, which play an import ant role in antimicrobiol immunity [8].

In respond to infection adenoid starts production in crypt epithelium proinflammatory Th1 cytokines, including TNF-α, IFN-γ, IL-2 and later secrete Th2 type cytokine ( IL-4, IL-5, IL-6, IL10, IL-13) [8]. Todorovic et al. demonstrated higher production of Th-1 cytokines (TNF-α, IFN-γ) in recurrent tonsillitis compared in tonsillar hypertrophy. In both forms of tonsilitis the production of Th-1 type cytokine was higher compoared to the production of Th-2- type cytokines. Bernstein found a decrease in the synthesis of Th1 cytokines IFN-γ and IL-2 in lymphoid tissue of patients with hypertrophic adenoids and recurrent otitis media. This author suggested that persistence of Th1 cytokines over Th2 could contribute to chronic inflammatory of hypertophic adenoid [9]. High concentrations of TNF-α, IL-8, IL-1β and IL-6 were found in children with chronic otitis media with effusion but in the non-atopic group. In the non-atopic group with bacterial isolate, TNF-α and IL-1β levels positively correlated with the number of past acute otitis media. High concentrations of the proinflammatory cytokine are involved locally in the zone of inflammation [10]. Lymphocytes T CD4+ and T follicular helper (Tfh) are responsible for assisting B lymphocytes to generate antibodies. These cells interact with ligands on the surface of lymphocytes B and start secretion of IL-21 and IL-4, IL-6, IL-8 and IgE which may be involved in the onset of adenoidal hypertrophy combined with secretory otitis media in children [11].

In our study we demonstrated higher IL-5 and TNF-α production in cell cultures stimulated with PHA in hypertophic adenoid in children with media with effusion than in hypertophic adenoid. There were no differences in the levels of cytokines 6, 8 and 10 in supernatants of cells isolated from two groups. Increased IL-5 production in middle ear effusion may be beneficial for the host, because this cytokine is important in the stimulation of the production of antibodies that would be responsible for a humoral immune response directed against potential pathogens [12].

The role of VEGF in hypertrophic adenoid

Pro-inflammatory cytokines such as TNF-α, transforming growth factor-beta (TGF-β), IL-1 can induce production of VEGF (vascular endothelial growth factor) from epithelial cells, vascular endothelial cells or monocytes. Berse et al. suggested that the stimulated and pathway for induction of VEGF may differ in different cell, like the nuclear factor kappa B (NF-κB) [13]. VEGF can also impact endothelial cell expression of immunologically important molecules, decreasing expression of VCAM-1 (vascular cell adhesion molecule-1) increasing expression of FasL, leading to apoptosis [14]. VEGF is produced by the middle ear mucosa and its concentration increases in the exudative and middle ear mucosa in patients with otitis media. Sekiyama et al. showed the higher concentration of endotoxin and IL-8 in most middle ear effusion samples. In their study the concentration of endotoxin were significantly correlated with VEGF levels. In contrast, here was no correlation between IL-8 and VEGF levels or between endotoxin and IL-8. Their results suggest that VEGF is produced in the middle ear in response to stimulation with endotoxin and hypoxic conditions [15]. Bacterial infections increase the levels of both VEGF and its receptors. Elevated cytokine concentrations lead to increased vascular permeability and elevated secretion of exudative fluid. Moreover, they affect the infection of inflammatory cells of the mucous membrane, thus leading to neovascularization within the middle ear [16].

In our study, the mean concentration levels of VEGF-A and TGF-β in hypertrophic adenoid in children with adenoid hypertrophy and otitis media with effusion were significantly higher compared to patients with adenoid hypertrophy. High levels of this cytokine may indicate a bacterial pathogen as one of the causes of exudative otitis media in children [17].

Apoptosis in hypertrophic adenoid

Germinal center of adenoid plays an important role in cell death and cell proliferation [18]. The increase in size and more number of germinal centers was found in patients with hypertrophy adenoid compared to those without hypertrophy. Onal et al. determined that the increased adenoid apoptosis was associated with age. The significantly increased of apoptosis in hypertrophy adenoid compared to chronic adenoid. The authors felt that increased apoptosis with increasing age might account for the noted involution of lymphoid tissue as patients get older [19]. The number of lymphocytes T and B in adenoid and their cooperation in the immunologic and morphological involution depends on their proliferation and migration status. Apoptosis as the process that regulates lymphocyte homeostasis is to a large extent responsible for the immune function of the hypertrophic adenoid [20]. Tumor necrosis factor receptor superfamily member (Fas receptor, CD95) is a death receptor localized on the surface of cells, which triggers a signal transduction pathway leading to apoptosis. Fas- mediated apoptosis is depending on cytokine-2 (IL-2).The interaction between Fas and ligand FasL (FasL/ CD95L) regulates pathological and physiological processes. In the Fas-mediated apoptotic pathway, binding of FasL drives Fas clustering and binding of Fas to FADD. FADD recruits caspase-8 and caspase-10 form the death- inducing signaling complex (DISC) [21]. The antiapoptotic molecule Bcl-2 and its homolog Bcl-xL in lymphocytes accumulate greatly increased number of T and B cells [22]. These molecules control transport through the pores on the external mitochondrial membrane and prevent the exit of cytochrome c from mitochondria and apoptosis initiation. Germinal center cells do not display the expression of Bcl-2, but in the mantel zone cells express a high level of Bcl-2 [23].

Higher percentages of lymphocytes T (CD4+ and CD8+ ) and lymphocytes B (CD19+ ) showing the expression of death receptor Fas in hypertrophic adenoid in children with exudative otitis media compared to hypertrophy adenoid. Statistically significantly lower percentages of lymphocytes CD4+ Bcl-2+ , CD8+ Bcl-2+ , CD19+ Bcl-2+ was found in the group of children with exudative otitis media. The tendency of reduced percentages of lympocytes T and B lymphocytes with Bcl-2+ expression and elevated percentages of these cells with CD95+ expression may reflect local immunity disorders [24].

The role of metalloproteinase in hypertrophic adenoid

Matrix metalloproteinases (MMP) are zinc-dependent endopeptidases which have a key role in the degradation of extracellular matrix. (MMP) and their inhibitors (TIMP) are produced during the inflammatory process by lymphocytes, neutrophils, macrophages, mast cells and eosinophils. The coordinate expressions of MMP and TIMP are involved, tissue remodeling cell transmigration during inflammatory disease, proliferation and apoptosis [25]. The literature shows that level of MMPs and TIMPs in relation to inflammatory and hypertrophic process in adenoids and the resulting otitis media with effusion. Guedez et al. demonstrated that TIMP-1 expressed by isolated germinal center B cells, but antiapoptotic mechanism is also not mediated by Bcl-2 nut likely inducing Bcl-xL [26]. Another author showed diffuse dissemination of MMPs activity in adenoid tissue. The level of MMP-7 and MMP-9 was higher of hypertrophied tissue, but no differences were observed in the level of TIMP-1 and MMP-2. The concentrations of MMP-8 and MMP-9 and TIMP1 in children with adenoid hypertrophy and secretory otitis media reached statistically significantly higher concentrations than those in children belonging to the reference group [27]. This result suggest that MMPs promotes of the extracellular matrix responded to inflammatory changes in adenoid tissue.

CONCLUSION

The different mediators of inflammation like cytokines, VEGF-A and TGF-β involved in the pathogenesis of otitis media with effusion in children. Incresed levels of pro-inflammatory cytokines (Th-1) suggest that abnormalities in the immune system triggering chronic, uncontrolled, inflammation may be a driver of disease. Elevated MMPs and TIMPs levels may induce an increased remodeling of the extracellular matrix. Indicate enhanced apoptosis of activated lymphocytes T and B, can lead to disturbances in local immune response involving the middle ear. Accurate recognition of inflammatory markers activity may become, a viable preventative or treatment in children with otitis media with effusion.

REFERENCES
  1. Silvia Regina Amorim Pereira, Silvia Fuerte Bakor, Luc Louis Maurice Weckx. Adenotonsillectomy in facial growing patients: spontaneous dental effects. Braz J Otorhinolaryngol. 2011; 77: 600-604.
  2. S Murat, I Akif, I Abdulkadir, A Hale, A Ibrahim, P Ercan, O Semih. Risk factors for otitis media with effusion in children with adenoid hypertrophy. Acta Otorhinolaryngol Ital. 2020; 40: 133-137.
  3. CC Goodnow, CG Vinuesa, KL Randall, F Mackay, R Brink. Control systems and decision making for antibody production. Nat Immunol. 2010; 11: 681-688.
  4. B León, FE Lund. Compartmentalization of dendritic cell and T-cell interactions in the lymph node: anatomy of T-cell fate decisions. Immunol Rev. 2019; 289: 84-100.
  5. Michal Kotowski, Artur Niedzielski, Grazyna Niedzielska, Patrycja Lachowska-Kotowska. Dendritic cells and lymphocyte subpopulations of the adenoid in the pathogenesis of otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2011; 75: 265-269.
  6. K Pazdro-Zastawny, T Zato?ski. The effect of middle ear effusion on the inner ear condition in children. Adv Clin Exp Med. 2020; 29: 325- 330.
  7. Romain Kania, Pierre Vironneau, Huong Dang, Béatrice Bercot, Emmanuelle Cambau, Benjamin Verillaud, et al. Bacterial biofilm in adenoids of children with chronic otitis media. Part I: a case control study of prevalence of biofilms in adenoids, risk factors and middle ear biofilms. Acta Otolaryngol. 2019; 139: 345-350.
  8. MM Todorovi?, E Zvrko. Immunoregulatory cytokines and chronic tonsillitis. Bosn J Basic Med Sci. 2013; 13: 230-236.
  9. JM Bernstein, M Ballow, S Xiang, KO’Neil. Th1/Th2 cytokine profiles in the nasopharyngeal lymphoid tissues of children with recurrent otitis media. Ann Otol Rhinol Laryngol. 1998; 107: 22-27.
  10. Beata Zielnik-Jurkiewicz, Wanda Stankiewicz-Szymczak. Pro- inflammatory interleukins in middle ear effusions from atopic and non-atopic children with chronic otitis media with effusion. Eur Arch Otorhinolaryngol. 2016; 273: 1369-1378.
  11. Chunyan Feng, Qicheng Zhang, Guangquan Zhou, Jing Zhang, Yanshu Zhang. Roles of T follicular helper cells in the pathogenesis of adenoidal hypertrophy combined with secretory otitis media. Medicine. 2018; 97: e0211.
  12. Beata Zelazowska-Rutkowska, Elzbieta Ilendo, Bozena Skotnicka, Jolanta Wysocka, Edwina Kasprzycka. Production of cytokines by mononuclear cells of hypertrophic adenoids in children with otitis media with effusion. Folia Histochem Cytobiol. 2012; 50: 586-589.
  13. B Berse, JA Hunt, RJ Diegel, P Morganelli, K Yeo, F Brown, RA Fava. Hypoxia augments cytokine (transforming growth factor-beta (TGF- beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol. 1999; 115: 176-182.
  14. Rajendra S Apte, Daniel S Chen, Napoleone Ferrara. VEGF in signaling and disease: beyond discovery and development. Cell. 2019; 176: 1248-1264.
  15. Kohsuke Sekiyama, Jun-ichiro Ohori, Shoji Matsune, Yuichi Kurono. The role of vascular endothelial growth factor in pediatric otitis media with effusion. Auris Nasus Larynx. 2011; 38: 319-324.
  16. NR London, RK Gurgel. The role of vascular endothelial growth factor

    and vascular stability in diseases of the ear. Laryngoscope. 2014; 124: 340-346.

  17. Beata Zelazowska-Rutkowska, Bozena Skotnicka, Bogdan Cylwik. Vascular endothelial growth factor and transforming growth factor β in hypertrophic adenoids in children suffering from otitis media with effusion. Cytokine. 2020; 133: 155125.
  18. Yang Zhang, Laura Garcia-Ibanez, Kai-Michael Toellner. Regulation ofgerminal center B-cell differentiation. Immunol Rev. 2016; 270: 8-19.
  19. Merih Önal, Taner Y?lmaz, Elif Bilgiç, Sevda Fatma Müftüo?lu, O?uz Ku?çu, R?za Önder Günayd?n. Apoptosis in chronic tonsillitis and tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2015; 79: 191-195.
  20. Jeffrey C Rathmell, Craig B Thompson. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002; 109: S97-107.
  21. A Yamada, R Arakaki, M Saito, Y Kudo, N Ishimaru. Dual role of Fas/FasL-mediated signal in peripheral immune Tolerance. Front Immunol. 2017; 5: 403-408.
  22. ML Hartman, M Czyz. BCL-w: apoptotic and non-apoptotic role inhealth and disease. Cell Death Dis. 2020; 11: 260-263.
  23. Tomás Kucera, Hana Pácová, David Veselý, Jaromír Astl, Jindrich Martínek. Apoptosis and cell proliferation in chronic tonsillitis and oropharyngeal carcinoma: role of nitric oxide and cytokines. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004; 148: 225-227.
  24. B ?elazowska-Rutkowska, J Wysocka, B Skotnicka. Chosen factors of T and B cell apoptosis in hypertrophic adenoid In children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 74 2010; 74: 698-700.
  25. Magnus S Ågren, Ulrich Auf dem Keller. Matrix metalloproteinases: How much can they Do? Int J Mol Sci. 2020; 21: 2678.
  26. L Guedez, L Courtemanch, M Stetler-Stevenson. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood. 1998; 92: 1342-1349.
  27. Beata Zelazowska-Rutkowska, Bozena Skotnicka, Elzbieta Hassmann- Poznanska, Bogdan Cylwik. Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2020; 128: 109700.
Received : 27 Jan 2022
Accepted : 07 Feb 2022
Published : 14 Feb 2022
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X